NDC 0944-4178 - CEPROTIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0944-4178
- Package NDCs from labels
- 0944-4178-02
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH
- Effective date
- 2025-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEPROTIN - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-12-04 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0944-4178-02 | CEPROTIN | 10 mL in 1 VIAL, GLASS | INJECTION, POWDER, LYOPHILIZED, | 10 mL | 1000 [iU] in 10mL | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROTEIN C | ACTIVE INGREDIENT | 3Z6S89TXPW | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 6 | |
| PROTEIN C | ACTIVE MOIETY | 3Z6S89TXPW | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 6 | |
| ALBUMIN HUMAN | INACTIVE INGREDIENT | ZIF514RVZR | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 6 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 6 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| N-10 | SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, AND BOS TAURUS PITUITARY GLAND, POSTERIOR | DNA Labs, Inc. | 264d8093-70f3-43a5-bfc4-b719bb3e45e6 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-16 | MGO ENERGIZER | DNA Labs, Inc. | 8292b900-86c1-47ea-81da-b587439c7664 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-21 | CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, AND SUS SCROFA EYE | DNA Labs, Inc. | 89967941-c4ee-4598-a66d-8a93d69a4d65 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-14 | FUCUS VESICULOSUS, SODIUM CHLORIDE, LYCOPUS VIRGINICUS, SPONGIA OFFICINALIS SKELETON, ROASTED, POTASSIUM IODIDE, CALCIUM IODIDE, THYROID, UNSPECIFIED, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS THYMUS, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 3d64739c-5d61-4e88-8612-d5f6994f1c3c | 2025-01-09 | Warnings | 451W47IQ8X |
| N-24 | METABOLIN | DNA Labs, Inc. | 559fca2b-1093-4bdf-be70-c453f87002c3 | 2025-01-09 | Warnings | 451W47IQ8X |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33 | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 7da788fc-3481-527f-e053-2a91aa0af6ac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| Emetrol Powder Non-Drowsy | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9d8d2ee7-9db7-4be7-8c73-511eb2e32459 | 2025-01-08 | Warnings | B22547B95K |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Shingles Remedy | CROTON TIGLIUM, NATRUM MURIATICUM, PLANTAGO MAJOR, RHUS TOX, SARSAPARILLA | Silver Star Brands | 5d65c997-f5dc-4dee-e053-2a91aa0ac319 | 2025-01-01 | Warnings | 451W47IQ8X |
| Mucus Clear Allergy Relief | ALLIU CEPA, CALC PHOS, EUPHRASIA, IGNATIA, KALI MUR, NAT MUR, NUX VOM, PULSATILLA, SILICA | Silver Star Brands | f49bdcc1-1939-6dc2-e053-2995a90a0a3b | 2025-01-01 | Warnings | 451W47IQ8X |
| Sweat-Less | ARG NIT, CASTOREUM, HUMULUS, IODUM, KALI PHOS, NAT MUR | Silver Star Brands | 4053d10b-4b06-291b-e054-00144ff88e88 | 2025-01-01 | Warnings | 451W47IQ8X |
| NativeRemedies Triple Complex Brain Tonic | CALC PHOS, KALI PHOS, NAT MUR. | Silver Star Brands | f76eaf46-4a80-31a9-e053-6394a90a542d | 2025-01-01 | Warnings | 451W47IQ8X |
| Headache Ease | AUR MET, BELLADONNA, BRYONIA, GELSEISUM, IGNATIA, KALI PHOS, NAT MUR, NUX VOM, SEPIA | Silver Star Brands | c689fb16-6200-ac94-e053-2995a90a703d | 2025-01-01 | Warnings | 451W47IQ8X |
| AllergiClear-M | ADRENALINUM, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, KALI MURIATICUM, NATRUM MURIATICUM, SILICEA | Silver Star Brands | 9d36096b-022f-5cfa-e053-2995a90a381f | 2025-01-01 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.